Changing susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients with the clinical use of newer antibiotics
Open Access
- 1 April 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (4) , 526-528
- https://doi.org/10.1128/aac.33.4.526
Abstract
To detect a change in antibiotic susceptibility patterns in Pseudomonas aeruginosa isolates upon the introduction and clinical use of ciprofloxacin, aztreonam, and ceftazidime, MICs for clinical isolates collected before introduction of the antibiotics, during early clinical use, and later were determined for these and seven other antipseudomonal antibiotics. Concomitant resistance to two or more antibiotics was also studied. Over the three study periods, rates of susceptibility to 9 of the 10 antibiotics decreased. The largest decrease occurred with ceftazidime. Analysis of subsets of isolates from patients treated with ciprofloxacin or aztreonam also showed declining susceptibility to the latter but a stabilization of susceptibility to the former after an initial decline. Concomitant resistance within and among antibiotic classes was common.This publication has 12 references indexed in Scilit:
- Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosisThe Pediatric Infectious Disease Journal, 1988
- Absence of rapidly developing resistance during treatment of cystic fibrosis patients with aztreonamDiagnostic Microbiology and Infectious Disease, 1987
- Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosisThe Pediatric Infectious Disease Journal, 1987
- ORAL CIPROFLOXACIN COMPARED WITH CONVENTIONAL INTRAVENOUS TREATMENT FOR PSEUDOMONAS AERUGINOSA INFECTION IN ADULTS WITH CYSTIC FIBROSISThe Lancet, 1987
- Antibiotic resistance of Pseudomonas speciesPublished by Elsevier ,1986
- Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosisThe Pediatric Infectious Disease Journal, 1985
- In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosisAntimicrobial Agents and Chemotherapy, 1984
- Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-PlaceboThe Journal of Infectious Diseases, 1983
- Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosisAntimicrobial Agents and Chemotherapy, 1982
- Azlocillin in Respiratory Tract Infections with Pseudomonas aeruginosa in Children with Cystic FibrosisChemotherapy, 1980